Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to...
Vous n'êtes pas connecté
One of the most effective treatments for cancer patients is to undergo chemotherapy treatment that will kill cancer cells in the body. However, this treatment also usually comes with side effects, one of which is hair loss.Chemotherapy treatment is usually done by injecting drugs into the patient's body to kill cancer cells, but comes with side effects such as lethargy, nausea and hair loss.Luminate Medical, a medical equipment manufacturing company is reported to be testing a new medical equipment that is expected to help reduce the issue of hair loss when going through this chemotherapy treatment.In a nutshell, the Luminate "helmet" gently compresses the blood vessels to the head to ensure that the chemotherapy drugs do not enter the area. Named Lily, this tool has been developed since 2021 and is currently undergoing a testing phase to test the effectiveness of this product.The company also says that the risk of blood flow restriction is also not an issue because compression therapy is something that has been tested and seen as safe for the public to use.However, as said before, Lily's hardware is still being tested for its effectiveness and safety. So far, some cancer patients have been tested with this equipment, and have undergone 4-12 chemotherapy treatments and still have hair on their heads.Luminate is now looking to enter an additional testing phase in several locations in the United States, including New York, Florida and possibly Ohio. It is expected that the number of patients who will help test Lily is a total of 85 people within a few months starting from this November.
Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to...
A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors....
Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received chemotherapy...
Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis. Current treatments could be...
Researchers and doctors from UCLA Health will present 23 studies covering lung cancer, pediatric cancer, survivorship, and healthcare equity,...
Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack tumour cells. However, only 20-40% of patients...
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung...
Trastuzumab deruxtecan shows substantial anti-cancer activity in brain metastases in patients with HER2-positive breast cancer in a major...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumour cell growth,...
With the global population ageing rapidly, sarcopenia, a condition that affects millions of older adults and severely diminishes their quality of...